database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,12 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,24 months,2,0.4158004158
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,36 months,3,0.6237006237
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Cancer,Solid Cancer,421,481,12 months,7,1.4553014553
MPCD,DMARD,Cancer,Solid Cancer,421,481,24 months,13,2.7027027027
MPCD,DMARD,Cancer,Solid Cancer,421,481,36 months,13,2.7027027027
MPCD,DMARD,Cancer,Solid Cancer,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,12 months,5,1.0395010395
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,24 months,6,1.2474012474
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,36 months,7,1.4553014553
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,12 months,19,3.9501039501
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,24 months,21,4.3659043659
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,36 months,21,4.3659043659
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,AS cohort entry to exposure,14,2.9106029106
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,12 months,12,2.4948024948
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,24 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,36 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,AS cohort entry to exposure,7,1.4553014553
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,12 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,24 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,36 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,12 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,24 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,36 months,1,0.2079002079
MPCD,DMARD,Kidney disease,Nephrotic syndrome,421,481,AS cohort entry to exposure,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,12 months,2,0.4158004158
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,24 months,3,0.6237006237
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,36 months,4,0.8316008316
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,12 months,7,1.4553014553
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,24 months,11,2.2869022869
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,36 months,14,2.9106029106
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,12 months,26,5.4054054054
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,24 months,30,6.237006237
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,36 months,31,6.4449064449
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,AS cohort entry to exposure,21,4.3659043659
MPCD,DMARD,Uveitis,Uveitis,421,481,12 months,35,7.2765072765
MPCD,DMARD,Uveitis,Uveitis,421,481,24 months,40,8.316008316
MPCD,DMARD,Uveitis,Uveitis,421,481,36 months,42,8.7318087318
MPCD,DMARD,Uveitis,Uveitis,421,481,AS cohort entry to exposure,28,5.8212058212
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,12 months,14,0.5399151562
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,24 months,21,0.8098727343
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,36 months,22,0.8484381026
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,AS cohort entry to exposure,2,0.0771307366
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,12 months,115,4.4350173544
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,24 months,157,6.054762823
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,36 months,171,6.5946779792
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,AS cohort entry to exposure,43,1.6583108369
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,12 months,48,1.8511376784
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,24 months,64,2.4681835712
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,36 months,71,2.7381411492
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,AS cohort entry to exposure,8,0.3085229464
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,12 months,25,0.9641342075
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,24 months,32,1.2340917856
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,36 months,37,1.4269186271
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,AS cohort entry to exposure,6,0.2313922098
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,12 months,13,0.5013497879
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,24 months,24,0.9255688392
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,36 months,25,0.9641342075
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,AS cohort entry to exposure,1,0.0385653683
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,12 months,88,3.3937524103
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,24 months,101,3.8951021982
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,36 months,108,4.1650597763
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,AS cohort entry to exposure,37,1.4269186271
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,12 months,49,1.8897030467
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,24 months,58,2.2367913614
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,36 months,60,2.313922098
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,AS cohort entry to exposure,25,0.9641342075
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,12 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,24 months,2,0.0771307366
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,36 months,3,0.1156961049
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,12 months,3,0.1156961049
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,24 months,6,0.2313922098
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,36 months,8,0.3085229464
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,AS cohort entry to exposure,2,0.0771307366
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,12 months,0,0
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,24 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,36 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Nephrotic syndrome,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,12 months,0,0
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,24 months,1,0.0385653683
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,36 months,1,0.0385653683
MPCD,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,12 months,2,0.0771307366
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,24 months,4,0.1542614732
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,36 months,4,0.1542614732
MPCD,NSAID or no exposure,Lung disease,Interstitial lung disease,2083,2593,AS cohort entry to exposure,1,0.0385653683
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,12 months,45,1.7354415735
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,24 months,68,2.6224450444
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,36 months,75,2.8924026224
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,AS cohort entry to exposure,22,0.8484381026
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,12 months,4,0.1542614732
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,24 months,5,0.1928268415
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,36 months,5,0.1928268415
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,AS cohort entry to exposure,3,0.1156961049
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,12 months,9,0.3470883147
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,24 months,11,0.4242190513
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,36 months,13,0.5013497879
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,AS cohort entry to exposure,4,0.1542614732
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,12 months,50,1.928268415
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,24 months,67,2.5838796761
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,36 months,72,2.7767065175
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,AS cohort entry to exposure,27,1.0412649441
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,12 months,63,2.4296182029
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,24 months,76,2.9309679907
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,36 months,86,3.3166216737
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,AS cohort entry to exposure,29,1.1183956807
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,12 months,162,6.2475896645
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,24 months,190,7.3274199769
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,36 months,202,7.7902043965
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,AS cohort entry to exposure,82,3.1623602005
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,24 months,6,0.4691164973
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,36 months,6,0.4691164973
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,AS cohort entry to exposure,5,0.3909304144
MPCD,TNF,Cancer,Solid Cancer,1107,1279,12 months,34,2.6583268178
MPCD,TNF,Cancer,Solid Cancer,1107,1279,24 months,42,3.2838154808
MPCD,TNF,Cancer,Solid Cancer,1107,1279,36 months,45,3.5183737295
MPCD,TNF,Cancer,Solid Cancer,1107,1279,AS cohort entry to exposure,20,1.5637216575
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,12 months,23,1.7982799062
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,24 months,30,2.3455824863
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,36 months,31,2.4237685692
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,AS cohort entry to exposure,18,1.4073494918
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,12 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,24 months,5,0.3909304144
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,36 months,5,0.3909304144
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,AS cohort entry to exposure,2,0.1563721658
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,24 months,7,0.5473025801
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,36 months,7,0.5473025801
MPCD,TNF,Cardiac disease,Myocardial infarction,1107,1279,AS cohort entry to exposure,3,0.2345582486
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,12 months,75,5.8639562158
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,24 months,82,6.4112587959
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,36 months,85,6.6458170446
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,AS cohort entry to exposure,66,5.1602814699
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,12 months,40,3.1274433151
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,24 months,46,3.5965598124
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,36 months,50,3.9093041439
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,AS cohort entry to exposure,27,2.1110242377
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,24 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,36 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,AS cohort entry to exposure,1,0.0781860829
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,12 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Kidney disease,Nephrotic syndrome,1107,1279,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,12 months,9,0.7036747459
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,24 months,15,1.1727912432
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,36 months,17,1.3291634089
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,AS cohort entry to exposure,10,0.7818608288
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,12 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,AS cohort entry to exposure,0,0
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,12 months,55,4.3002345582
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,24 months,67,5.2384675528
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,36 months,72,5.6293979672
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,AS cohort entry to exposure,37,2.8928850665
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,12 months,83,6.4894448788
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,24 months,98,7.662236122
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,36 months,103,8.0531665364
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,AS cohort entry to exposure,70,5.4730258014
MPCD,TNF,Uveitis,Uveitis,1107,1279,12 months,108,8.4440969507
MPCD,TNF,Uveitis,Uveitis,1107,1279,24 months,121,9.4605160281
MPCD,TNF,Uveitis,Uveitis,1107,1279,36 months,126,9.8514464425
MPCD,TNF,Uveitis,Uveitis,1107,1279,AS cohort entry to exposure,90,7.036747459
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,12 months,20,0.97799511
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,24 months,28,1.369193154
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,36 months,31,1.5158924205
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,AS cohort entry to exposure,14,0.684596577
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,12 months,35,1.7114914425
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,24 months,56,2.7383863081
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,36 months,63,3.0806845966
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,AS cohort entry to exposure,22,1.075794621
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,12 months,106,5.1833740831
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,24 months,132,6.4547677262
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,36 months,144,7.0415647922
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,AS cohort entry to exposure,76,3.7163814181
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,12 months,38,1.858190709
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,24 months,49,2.3960880196
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,36 months,54,2.6405867971
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,AS cohort entry to exposure,19,0.9290953545
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,12 months,37,1.8092909535
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,24 months,50,2.4449877751
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,36 months,50,2.4449877751
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,AS cohort entry to exposure,25,1.2224938875
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,24 months,6,0.293398533
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,36 months,8,0.391198044
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,AS cohort entry to exposure,5,0.2444987775
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,12 months,84,4.1075794621
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,24 months,96,4.6943765281
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,36 months,100,4.8899755501
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,AS cohort entry to exposure,73,3.5696821516
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,12 months,68,3.3251833741
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,24 months,83,4.0586797066
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,36 months,87,4.2542787286
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,AS cohort entry to exposure,36,1.760391198
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,12 months,0,0
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,24 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,36 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Amyloidosis,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,24 months,3,0.1466992665
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,36 months,3,0.1466992665
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,AS cohort entry to exposure,2,0.097799511
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,12 months,1,0.0488997555
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,24 months,2,0.097799511
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,36 months,3,0.1466992665
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,24 months,4,0.195599022
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,36 months,4,0.195599022
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,AS cohort entry to exposure,2,0.097799511
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,12 months,64,3.1295843521
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,24 months,81,3.9608801956
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,36 months,90,4.4009779951
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,AS cohort entry to exposure,50,2.4449877751
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,24 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,36 months,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,AS cohort entry to exposure,3,0.1466992665
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,12 months,11,0.5378973105
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,24 months,19,0.9290953545
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,36 months,21,1.0268948655
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,AS cohort entry to exposure,5,0.2444987775
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,12 months,78,3.8141809291
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,24 months,92,4.4987775061
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,36 months,105,5.1344743276
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,AS cohort entry to exposure,54,2.6405867971
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,12 months,149,7.2860635697
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,24 months,168,8.2151589242
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,36 months,176,8.6063569682
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,AS cohort entry to exposure,98,4.7921760391
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,12 months,185,9.0464547677
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,24 months,212,10.366748166
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,36 months,225,11.002444988
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,AS cohort entry to exposure,128,6.2591687042
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,12 months,85,0.8027198036
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,24 months,107,1.0104825763
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,36 months,118,1.1143639626
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,AS cohort entry to exposure,50,0.4721881197
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,12 months,195,1.841533667
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,24 months,290,2.7386910945
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,36 months,345,3.2580980263
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,AS cohort entry to exposure,95,0.8971574275
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,12 months,559,5.2790631788
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,24 months,677,6.3934271414
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,36 months,724,6.8372839739
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,AS cohort entry to exposure,260,2.4553782227
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,12 months,239,2.2570592124
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,24 months,299,2.8236849561
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,36 months,333,3.1447728775
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,AS cohort entry to exposure,102,0.9632637643
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,12 months,245,2.3137217868
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,24 months,330,3.1164415903
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,36 months,362,3.418641987
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,AS cohort entry to exposure,102,0.9632637643
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,12 months,70,0.6610633676
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,24 months,86,0.812163566
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,36 months,99,0.9349324771
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,AS cohort entry to exposure,39,0.3683067334
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,12 months,333,3.1447728775
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,24 months,381,3.5980734725
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,36 months,403,3.8058362452
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,AS cohort entry to exposure,181,1.7093209935
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,12 months,266,2.5120407971
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,24 months,305,2.8803475305
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,36 months,326,3.0786665407
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,AS cohort entry to exposure,104,0.9821512891
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,12 months,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,24 months,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,36 months,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,12 months,10,0.0944376239
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,24 months,14,0.1322126735
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,36 months,17,0.1605439607
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,AS cohort entry to exposure,3,0.0283312872
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,12 months,5,0.047218812
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,24 months,7,0.0661063368
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,36 months,7,0.0661063368
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,12 months,2,0.0188875248
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,24 months,2,0.0188875248
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,36 months,2,0.0188875248
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,12 months,11,0.1038813863
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,24 months,13,0.1227689111
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,36 months,14,0.1322126735
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,AS cohort entry to exposure,6,0.0566625744
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,12 months,380,3.5886297101
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,24 months,484,4.5707809992
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,36 months,556,5.2507318916
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,AS cohort entry to exposure,149,1.4071205968
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,12 months,9,0.0849938616
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,24 months,10,0.0944376239
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,36 months,10,0.0944376239
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,AS cohort entry to exposure,3,0.0283312872
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,12 months,68,0.6421758429
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,24 months,87,0.8216073284
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,36 months,93,0.8782699027
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,AS cohort entry to exposure,29,0.2738691095
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,12 months,235,2.2192841628
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,24 months,289,2.7292473321
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,36 months,329,3.1069978279
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,AS cohort entry to exposure,113,1.0671451506
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,12 months,307,2.8992350552
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,24 months,363,3.4280857494
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,36 months,395,3.730286146
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,AS cohort entry to exposure,176,1.6621021815
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,12 months,1042,9.8404004155
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,24 months,1188,11.219189725
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,36 months,1244,11.748040419
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,AS cohort entry to exposure,473,4.4668996128
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,12 months,18,0.3114725731
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,24 months,26,0.4499048278
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,36 months,27,0.4672088597
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,AS cohort entry to exposure,8,0.1384322547
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,12 months,82,1.4189306108
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,24 months,129,2.2322201073
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,36 months,156,2.6994289669
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,AS cohort entry to exposure,65,1.1247620696
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,12 months,145,2.5090846167
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,24 months,196,3.3915902405
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,36 months,210,3.6338466863
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,AS cohort entry to exposure,109,1.8861394705
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,12 months,81,1.401626579
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,24 months,107,1.8515314068
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,36 months,120,2.0764838207
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,AS cohort entry to exposure,56,0.969025783
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,12 months,72,1.2458902924
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,24 months,101,1.7477072158
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,36 months,114,1.9726596297
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,AS cohort entry to exposure,51,0.8825056238
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,12 months,11,0.1903443502
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,24 months,20,0.3460806368
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,36 months,21,0.3633846686
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,AS cohort entry to exposure,16,0.2768645094
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,12 months,352,6.0910192075
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,24 months,396,6.8523966084
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,36 months,406,7.0254369268
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,AS cohort entry to exposure,287,4.9662571379
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,12 months,251,4.3433119917
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,24 months,287,4.9662571379
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,36 months,300,5.1912095518
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,AS cohort entry to exposure,196,3.3915902405
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,12 months,2,0.0346080637
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,24 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,36 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,12 months,10,0.1730403184
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,24 months,12,0.2076483821
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,36 months,13,0.2249524139
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,AS cohort entry to exposure,7,0.1211282229
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,12 months,4,0.0692161274
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,24 months,6,0.103824191
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,36 months,7,0.1211282229
Marketscan,TNF,Kidney disease,Nephrotic syndrome,4797,5779,AS cohort entry to exposure,3,0.0519120955
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,12 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,24 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,36 months,1,0.0173040318
Marketscan,TNF,Lung disease,Apical Pulmonary fibrosis,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,12 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,24 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,36 months,6,0.103824191
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,AS cohort entry to exposure,4,0.0692161274
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,12 months,135,2.3360442983
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,24 months,186,3.2185499221
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,36 months,202,3.4954144316
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,AS cohort entry to exposure,119,2.0591797889
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,24 months,1,0.0173040318
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,36 months,2,0.0346080637
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,AS cohort entry to exposure,1,0.0173040318
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,12 months,15,0.2595604776
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,24 months,27,0.4672088597
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,36 months,36,0.6229451462
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,AS cohort entry to exposure,5,0.0865201592
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,12 months,275,4.7586087558
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,24 months,347,6.0044990483
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,36 months,388,6.7139643537
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,AS cohort entry to exposure,196,3.3915902405
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,12 months,469,8.1155909327
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,24 months,549,9.4999134798
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,36 months,570,9.8632981485
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,AS cohort entry to exposure,397,6.8697006402
Marketscan,TNF,Uveitis,Uveitis,4797,5779,12 months,597,10.330507008
Marketscan,TNF,Uveitis,Uveitis,4797,5779,24 months,677,11.714829555
Marketscan,TNF,Uveitis,Uveitis,4797,5779,36 months,708,12.251254542
Marketscan,TNF,Uveitis,Uveitis,4797,5779,AS cohort entry to exposure,502,8.6866239834
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,12 months,111,2.1374927787
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,24 months,150,2.8885037551
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,36 months,171,3.2928942808
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,AS cohort entry to exposure,112,2.1567494704
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,12 months,117,2.2530329289
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,24 months,200,3.8513383401
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,36 months,259,4.9874831504
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,AS cohort entry to exposure,97,1.8678990949
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,12 months,523,10.071249759
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,24 months,686,13.210090506
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,36 months,787,15.155016368
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,AS cohort entry to exposure,450,8.6655112652
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,12 months,324,6.2391681109
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,24 months,484,9.320238783
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,36 months,576,11.091854419
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,AS cohort entry to exposure,303,5.8347775852
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,12 months,255,4.9104563836
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,24 months,386,7.4330829963
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,36 months,466,8.9736183324
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,AS cohort entry to exposure,240,4.6216060081
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,12 months,47,0.9050645099
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,24 months,86,1.6560754862
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,36 months,125,2.4070864625
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,AS cohort entry to exposure,54,1.0398613518
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,12 months,361,6.9516657038
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,24 months,396,7.6256499133
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,36 months,415,7.9915270557
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,AS cohort entry to exposure,352,6.7783554785
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,12 months,241,4.6408626998
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,24 months,288,5.5459272097
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,36 months,320,6.1621413441
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,AS cohort entry to exposure,246,4.7371461583
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,12 months,3,0.0577700751
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,24 months,3,0.0577700751
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,36 months,3,0.0577700751
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,AS cohort entry to exposure,3,0.0577700751
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,12 months,16,0.3081070672
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,24 months,24,0.4621606008
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,36 months,30,0.577700751
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,AS cohort entry to exposure,23,0.4429039091
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,12 months,14,0.2695936838
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,24 months,21,0.4043905257
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,36 months,22,0.4236472174
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,AS cohort entry to exposure,9,0.1733102253
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,12 months,4,0.0770267668
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,24 months,4,0.0770267668
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,36 months,4,0.0770267668
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,AS cohort entry to exposure,3,0.0577700751
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,12 months,20,0.385133834
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,24 months,29,0.5584440593
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,36 months,34,0.6547275178
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,AS cohort entry to exposure,16,0.3081070672
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,12 months,546,10.514153668
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,24 months,753,14.50028885
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,36 months,915,17.619872906
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,AS cohort entry to exposure,597,11.496244945
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,12 months,1,0.0192566917
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,24 months,3,0.0577700751
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,36 months,5,0.0962834585
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,AS cohort entry to exposure,12,0.2310803004
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,12 months,40,0.770267668
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,24 months,63,1.2131715771
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,36 months,70,1.347968419
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,AS cohort entry to exposure,58,1.1168881186
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,12 months,276,5.3148469093
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,24 months,360,6.9324090121
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,36 months,415,7.9915270557
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,AS cohort entry to exposure,277,5.334103601
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,12 months,477,9.1854419411
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,24 months,548,10.552667052
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,36 months,590,11.361448103
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,AS cohort entry to exposure,444,8.549971115
Medicare,DMARD,Uveitis,Uveitis,4231,5193,12 months,339,6.5280184864
Medicare,DMARD,Uveitis,Uveitis,4231,5193,24 months,424,8.164837281
Medicare,DMARD,Uveitis,Uveitis,4231,5193,36 months,473,9.1084151743
Medicare,DMARD,Uveitis,Uveitis,4231,5193,AS cohort entry to exposure,359,6.9131523204
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,12 months,597,2.2854299058
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,24 months,738,2.8252048082
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,36 months,827,3.1659137891
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,AS cohort entry to exposure,373,1.4279151673
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,12 months,962,3.6827195467
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,24 months,1436,5.4972819845
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,36 months,1733,6.6342546513
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,AS cohort entry to exposure,383,1.4661970753
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,12 months,3535,13.532654467
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,24 months,4268,16.338718322
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,36 months,4711,18.034606845
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,AS cohort entry to exposure,1923,7.3616109027
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,12 months,2070,7.9243549499
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,24 months,2747,10.516040119
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,36 months,3162,12.1047393
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,AS cohort entry to exposure,1146,4.3871066534
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,12 months,1970,7.5415358701
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,24 months,2664,10.198300283
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,36 months,3114,11.920986142
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,AS cohort entry to exposure,1108,4.2416354031
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,12 months,438,1.6767475691
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,24 months,649,2.4844958273
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,36 months,786,3.0089579665
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,AS cohort entry to exposure,261,0.999157798
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,12 months,1145,4.3832784626
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,24 months,1290,4.9383661282
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,36 months,1378,5.2752469183
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,AS cohort entry to exposure,770,2.9477069137
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,12 months,721,2.7601255647
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,24 months,922,3.5295919149
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,36 months,1045,4.0004593829
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,AS cohort entry to exposure,481,1.8413597734
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,12 months,29,0.1110175331
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,24 months,33,0.1263302963
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,36 months,38,0.1454712503
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,AS cohort entry to exposure,21,0.0803920067
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,12 months,83,0.3177398362
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,24 months,121,0.4632110864
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,36 months,151,0.5780568104
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,AS cohort entry to exposure,76,0.2909425006
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,12 months,56,0.2143786846
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,24 months,74,0.283286119
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,36 months,83,0.3177398362
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,AS cohort entry to exposure,24,0.0918765791
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,12 months,10,0.038281908
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,24 months,12,0.0459382896
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,36 months,13,0.0497664804
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,AS cohort entry to exposure,6,0.0229691448
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,12 months,37,0.1416430595
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,24 months,53,0.2028941122
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,36 months,67,0.2564887834
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,AS cohort entry to exposure,31,0.1186739147
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,12 months,2790,10.680652324
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,24 months,3926,15.029477069
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,36 months,4615,17.667100528
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,AS cohort entry to exposure,1775,6.7950386647
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,12 months,56,0.2143786846
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,24 months,69,0.264145165
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,36 months,72,0.2756297374
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,AS cohort entry to exposure,35,0.1339866779
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,12 months,384,1.4700252661
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,24 months,464,1.7762805298
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,36 months,516,1.9753464513
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,AS cohort entry to exposure,216,0.8268892122
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,12 months,886,3.3917770462
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,24 months,1157,4.4292167522
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,36 months,1296,4.961335273
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,AS cohort entry to exposure,617,2.3619937218
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,12 months,919,3.5181073425
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,24 months,1091,4.1765561596
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,36 months,1194,4.5708598117
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,AS cohort entry to exposure,771,2.9515351045
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,12 months,1303,4.9881326085
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,24 months,1666,6.3777658679
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,36 months,1868,7.1510604089
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,AS cohort entry to exposure,1018,3.8970982314
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,12 months,57,0.9613762861
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,24 months,87,1.467363805
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,36 months,111,1.8721538202
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,AS cohort entry to exposure,70,1.1806375443
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,12 months,122,2.0576825772
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,24 months,189,3.1877213695
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,36 months,251,4.2334289088
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,AS cohort entry to exposure,108,1.8215550683
Medicare,TNF,Cancer,Solid Cancer,4866,5929,12 months,443,7.4717490302
Medicare,TNF,Cancer,Solid Cancer,4866,5929,24 months,578,9.7486928656
Medicare,TNF,Cancer,Solid Cancer,4866,5929,36 months,674,11.367852926
Medicare,TNF,Cancer,Solid Cancer,4866,5929,AS cohort entry to exposure,411,6.93202901
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,12 months,269,4.5370214201
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,24 months,388,6.5441052454
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,36 months,464,7.8259402935
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,AS cohort entry to exposure,286,4.8237476809
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,12 months,218,3.6768426379
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,24 months,332,5.59959521
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,36 months,416,7.0163602631
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,AS cohort entry to exposure,232,3.9129701467
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,12 months,29,0.4891212683
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,24 months,62,1.0457075392
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,36 months,87,1.467363805
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,AS cohort entry to exposure,58,0.9782425367
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,12 months,527,8.8885140833
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,24 months,572,9.6474953618
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,36 months,594,10.018552876
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,AS cohort entry to exposure,500,8.4331253162
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,12 months,283,4.773148929
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,24 months,353,5.9537864733
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,36 months,390,6.5778377467
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,AS cohort entry to exposure,309,5.2116714454
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,12 months,6,0.1011975038
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,24 months,12,0.2023950076
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,36 months,12,0.2023950076
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,AS cohort entry to exposure,7,0.1180637544
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,12 months,15,0.2529937595
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,24 months,28,0.4722550177
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,36 months,36,0.6071850228
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,AS cohort entry to exposure,23,0.3879237645
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,12 months,14,0.2361275089
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,24 months,25,0.4216562658
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,36 months,32,0.5397200202
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,AS cohort entry to exposure,8,0.1349300051
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,12 months,0,0
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,24 months,0,0
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,36 months,0,0
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,AS cohort entry to exposure,1,0.0168662506
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,12 months,6,0.1011975038
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,24 months,11,0.185528757
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,36 months,15,0.2529937595
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,AS cohort entry to exposure,11,0.185528757
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,12 months,430,7.252487772
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,24 months,678,11.435317929
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,36 months,825,13.914656772
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,AS cohort entry to exposure,533,8.9897115871
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,12 months,8,0.1349300051
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,24 months,14,0.2361275089
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,36 months,15,0.2529937595
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,AS cohort entry to exposure,7,0.1180637544
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,12 months,35,0.5903187721
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,24 months,54,0.9107775342
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,36 months,70,1.1806375443
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,AS cohort entry to exposure,59,0.9951087873
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,12 months,447,7.5392140327
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,24 months,555,9.360769101
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,36 months,603,10.170349131
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,AS cohort entry to exposure,421,7.1006915163
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,12 months,694,11.705177939
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,24 months,790,13.324338
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,36 months,850,14.336313038
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,AS cohort entry to exposure,700,11.806375443
Medicare,TNF,Uveitis,Uveitis,4866,5929,12 months,564,9.5125653567
Medicare,TNF,Uveitis,Uveitis,4866,5929,24 months,688,11.603980435
Medicare,TNF,Uveitis,Uveitis,4866,5929,36 months,774,13.05447799
Medicare,TNF,Uveitis,Uveitis,4866,5929,AS cohort entry to exposure,583,9.8330241187
